Blue Barn Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,277
Closed -$292K 124
2025
Q3
$292K Buy
2,277
+92
+4% +$11.2K 0.13% 113
2025
Q2
$264K Sell
2,185
-1
-0% -$113 0.12% 128
2025
Q1
$244K Buy
2,186
+26
+1% +$2.77K 0.13% 126
2024
Q4
$210K Buy
2,160
+52
+2% +$5.54K 0.11% 138
2024
Q3
$242K Buy
2,108
+102
+5% +$11.6K 0.12% 127
2024
Q2
$214K Buy
+2,006
New +$201K 0.12% 124

Other funds holding NVS

Blue Barn Wealth's NVS Position: Q4 2025 in Review

Blue Barn Wealth sold out of Novartis (NVS) in Q4 2025, closing a stake of 2,277 shares — an estimated $292K sold.

Blue Barn Wealth first reported a position in NVS in Q2 2024 and held it in 6 quarters. The position peaked at $292K in Q3 2025. 1,508 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • Blue Barn Wealth reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • Blue Barn Wealth sold 2,277 Novartis shares in Q4 2025, an estimated $292K.
  • Blue Barn Wealth first reported a position in Novartis in Q2 2024 and held it in 6 quarters.
  • Blue Barn Wealth's Novartis position peaked at $292K in Q3 2025.
  • 1,508 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Blue Barn Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.